COMPARISON OF ENGERIX-B AND HEPLISAV-B VACCINE SEROPROTECTION RATES IN DIALYSIS

被引：0
|
作者：
Manley, Harold J. [1 ]
Aweh, Gideon [1 ]
Frament, Jill [1 ]
Ladik, Vlad [1 ]
Lacson, Eduardo, Jr. [1 ,2 ]
机构：
[1] Dialysis Clin Inc, Nashville, TN USA
[2] Tufts Med Ctr, Boston, MA 02111 USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2021年 / 77卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
180
引用
收藏
页码：623 / 623
页数：1
相关论文
共 50 条
  • [1] A real world comparison of HepB (Engerix-B®) and HepB-CpG (Heplisav-B®) vaccine seroprotection in patients receiving maintenance dialysis
    Manley, Harold J.
    Aweh, Gideon
    Frament, Jill
    Ladik, Vladimir
    Lacson, Eduardo K., Jr.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (02) : 447 - 454
  • [2] Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease
    Waseem Amjad
    Joseph Alukal
    Talan Zhang
    Anurag Maheshwari
    Paul J. Thuluvath
    Digestive Diseases and Sciences, 2021, 66 : 2101 - 2106
  • [3] Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease
    Amjad, Waseem
    Alukal, Joseph
    Zhang, Talan
    Maheshwari, Anurag
    Thuluvath, Paul J.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (06) : 2101 - 2106
  • [4] The safety profile of the investigational adult hepatitis B vaccine Heplisav is comparable with that of the currently available Engerix-B,
    Reactions Weekly, 2010, 1298 (1) : 2 - 2
  • [5] HIGH RATE OF SEROPROTECTION WITH HEPLISAV-B IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hegde, Yash
    Lazarus, Sarah
    Farraye, Francis A.
    Hayney, Mary S.
    Caldera, Freddy
    GASTROENTEROLOGY, 2024, 166 (05) : S1453 - S1454
  • [6] Heplisav-B: A Hepatitis B Vaccine With a Novel Adjuvant
    Champion, Caroline R.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (06) : 783 - 791
  • [7] Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease
    Girndt, Matthias
    Houser, Patricia
    Manllo-Karim, Roberto
    Ervin, John E.
    Charytan, Chaim
    Chow, Stephen
    Symonian-Silver, Margarita
    Lehrner, Lawrence
    Linfert, Douglas
    Shemin, Douglas
    Michelsen, Ann
    Xie, Fang
    Janssen, Robert S.
    VACCINE, 2023, 41 (20) : 3224 - 3232
  • [8] Recently Approved Heplisav-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted] Shows a Lower Proportion of Subjects with Non-and Low Response Compared with Engerix-B® [Hepatitis B Vaccine (Recombinant)] in Pooled Analysis of Trials
    Hyer, Randall
    Janssen, Robert S.
    HEPATOLOGY, 2018, 68 : 231A - 232A
  • [9] Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine
    Kuan, Renee Kim
    Janssen, Robert
    Heyward, William
    Bennett, Sean
    Nordyke, Robert
    VACCINE, 2013, 31 (37) : 4024 - 4032
  • [10] Heplisav-B in Prior Hepatitis B Vaccine Nonresponders: A Case Series
    Williams, Alan L.
    MILITARY MEDICINE, 2022, 187 (7-8) : E811 - E813
12345